These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21234830)

  • 1. Pharmacoeconomics of intravenous immunoglobulin in various neurological disorders.
    Tsai CP
    Acta Neurol Taiwan; 2010 Dec; 19(4):303-8. PubMed ID: 21234830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with intravenous immunoglobulin in neurological diseases. A descriptive study of effects seen from the patient's and health services' perspectives].
    Wintzell A; Eriksson T; Lundgren A; Petersson J
    Lakartidningen; 2008 May 21-27; 105(21):1571-5. PubMed ID: 18574994
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacoeconomics of immunoglobulins and indications for their use.
    Guillevin L
    Curr Opin Allergy Clin Immunol; 2013 Jul; 13 Suppl 2():S53-5. PubMed ID: 23873314
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
    Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
    J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics of therapy for ITP: steroids, i.v.Ig, anti-D, and splenectomy.
    Adams JR; Nathan DP; Bennett CL
    Blood Rev; 2002 Mar; 16(1):65-7. PubMed ID: 11913999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on "Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin".
    Buenz EJ
    J Clin Neurosci; 2009 Aug; 16(8):1110; author reply 1111. PubMed ID: 19467870
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment in neurological diseases.
    Otten A; Vermeulen M; Bossuyt PM; Otten A
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):359-61. PubMed ID: 8774395
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases].
    Lewańska M; Selmaj K
    Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of immunoglobulin in the therapy of neurological illnesses].
    Elovaara I; Färkkilä M; Hietaharju A; Pirttilä T
    Duodecim; 2001; 117(10):1033-41; quiz 1041, 1081. PubMed ID: 12116461
    [No Abstract]   [Full Text] [Related]  

  • 10. A practical approach to the use of intravenous immunoglobulin in neurological disease.
    Wills AJ; Unsworth DJ
    Eur Neurol; 1998; 39(1):3-8. PubMed ID: 9476717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulins in neurological diseases.
    Zettl UK; Mix E
    J Neurol; 2006 Sep; 253 Suppl 5():V1. PubMed ID: 16998748
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined use of plasma exchange and intravenous immunoglobulins.
    Nydegger UE; Rieben R
    Ann Med Interne (Paris); 1994; 145(5):287-92. PubMed ID: 7985933
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immunoglobulin (IVIG).
    Med Lett Drugs Ther; 2006 Dec; 48(1249/1250):101-3. PubMed ID: 17149360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expert opinion on use of intravenous immunoglobulins in the management of neurological disorders].
    Stępień A; Korsak J; Kozubski W; Ryglewicz D; Losy J; Drozdowski W; Kotowicz J; Nyka W; Kwieciński H
    Neurol Neurochir Pol; 2011; 45(6):525-35. PubMed ID: 22212982
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center.
    Ducruet T; Levasseur MC; Des Roches A; Kafal A; Dicaire R; Haddad E
    J Allergy Clin Immunol; 2013 Feb; 131(2):585-7.e1-3. PubMed ID: 23040368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of intravenous immunoglobulin in neurological disorders].
    Steck AJ
    Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
    Orange JS; Hossny EM; Weiler CR; Ballow M; Berger M; Bonilla FA; Buckley R; Chinen J; El-Gamal Y; Mazer BD; Nelson RP; Patel DD; Secord E; Sorensen RU; Wasserman RL; Cunningham-Rundles C;
    J Allergy Clin Immunol; 2006 Apr; 117(4 Suppl):S525-53. PubMed ID: 16580469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues.
    Gold R; Stangel M; Dalakas MC
    Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin therapy for neurological disorders.
    Harkins C; Hammond-Tooke G; Faed J
    N Z Med J; 2009 Oct; 122(1305):41-6. PubMed ID: 19966877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
    Elovaara I; Hietaharju A
    Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.